|
Market Closed -
Nasdaq
00:00:00 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 9.520 USD | +1.82% |
|
-5.27% | +81.33% |
| 09-10 | Canaccord Genuity Initiates Coverage on 908 Devices With Buy Rating, $13.50 Price Target | MT |
| 08-11 | 908 Devices Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Diagnostic & Testing Equipment
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 393M | - | - | - | ||
| 16.73B | |||||
| 1.75B | - | - | |||
| 893M | |||||
| 808M | - | ||||
| 778M | - | - |
- Stock Market
- Stocks
- MASS Stock
- Charts 908 Devices Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
